GREGORY D PERRY Insider Trading $AEGR Aegerion Pharmaceuticals, Inc.
Get free email notifications about insider trading for GREGORY D PERRY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GREGORY D PERRY. GREGORY D PERRY is See Remarks in QLT INC/BC ($QLTI) and Sr. VP & CFO in TRANSKARYOTIC THERAPIES INC ($TKTX) and VP, Finance & CEO in TRANSKARYOTIC THERAPIES INC ($TKTX) and VP, Finance and CFO in TRANSKARYOTIC THERAPIES INC ($TKTX) and Director in Ocata Therapeutics, Inc. ($ACTC) and in Aegerion Pharmaceuticals, Inc. ($AEGR) and Chief Financial Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and See Remarks in Aegerion Pharmaceuticals, Inc. ($AEGR) and in Kala Pharmaceuticals, Inc. ($KALA) and Director in Kala Pharmaceuticals, Inc. ($KALA) and Chief Financial and Business in Eleven Biotherapeutics, Inc. ($EBIO) and Chief Financial Officer in Finch Therapeutics Group, Inc. ($FNCH).
GREGORY D PERRY in Aegerion Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GREGORY D PERRY:
Holdings: 0 shares
Latest Transaction: Nov 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of GREGORY D PERRY in Aegerion Pharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AEGR, FNCH, KALA, NVLN, ACTC, SESN, TKTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 0.00 | 35,000 | 0 | 0 | ||
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 2.46 | 69,000 | 169,740 | 0 | ||
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 5.71 | 200,000 | 1,142,000 | 0 | ||
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 19.52 | 40,000 | 780,800 | 0 | ||
| Nov 30 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Option Exercise | D | 19.58 | 200,000 | 3,916,000 | 0 | ||
| May 11 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | See Remarks | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
| May 11 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | See Remarks | Option Exercise | A | 2.46 | 69,000 | 169,740 | 69,000 | |
| Feb 17 2016 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | See Remarks | Option Exercise | A | 5.71 | 200,000 | 1,142,000 | 200,000 | |
| Aug 06 2015 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Chief Financial Off ... | Option Exercise | A | 19.52 | 40,000 | 780,800 | 40,000 | |
| Aug 04 2015 | AEGR | Aegerion Pharmaceu ... | PERRY GREGORY D | Chief Financial Off ... | Option Exercise | A | 19.58 | 200,000 | 3,916,000 | 200,000 |
Page: 1